Physician

Charles H Koo, M.D.

According to 2025 Medicare claims, Charles Koo, M.D. (NPI: 1396782595) practices cardiac electrophysiology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is MONMOUTH CARDIOLOGY ASSOCIATES, LLC (NPI: 1285601674; TIN: 223460933) and primary practice location at 07724-2242.

Koo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,502 traditional Medicare patients, billed 9,075 HCPCS/CPT codes, and received $695,194 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,399 prescription claims across 600 beneficiaries totaling $1,626,214 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 75 claims. Open Payments data shows 19 records totaling $2,501. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $237,522 to $1,626,214. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,924	5,596	$437,452
2016	2,241	7,520	$442,404
2017	2,328	8,640	$508,902
2018	2,269	9,463	$543,142
2019	2,159	8,540	$627,176
2020	2,203	9,026	$556,566
2021	2,288	9,737	$623,318
2022	2,192	10,096	$638,690
2023	2,392	9,833	$618,069
2024	2,502	9,075	$695,194

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	217	1,558	$237,522
2016	232	1,909	$310,859
2017	284	2,162	$427,689
2018	312	2,370	$508,436
2019	349	2,802	$676,035
2020	367	3,019	$792,034
2021	428	3,219	$917,104
2022	492	3,712	$1,074,734
2023	519	3,859	$1,303,768
2024	600	4,399	$1,626,214

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$19,723
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	75	$5,464
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	346	446	$147
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	568	861	$100
93298	Evaluation of cardiac rhythm monitor system, remote up to 30 days	485	1,233	$88
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	723	1,126	$25
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	1,001	1,537	$19

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	501	31,575	$578,728
Xarelto	Rivaroxaban	372	24,296	$435,006
Entresto	Sacubitril/Valsartan	171	9,177	$195,848
Multaq	Dronedarone Hcl	24	1,560	$35,010
Dofetilide	Dofetilide	142	10,404	$26,204

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$2,501	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles H. Koo, M.D.?

Tedicare shows public-source Medicare data for Charles H. Koo, M.D. (NPI 1396782595), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles H. Koo, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles H. Koo, M.D.?

Charles H. Koo, M.D. is linked to MONMOUTH CARDIOLOGY ASSOCIATES, LLC (billing NPI 1285601674) in the available physician profile data.

Does Charles H. Koo, M.D. have Open Payments data?

Charles H. Koo, M.D. has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.